VAXZEVRIA - COVID-19 Vaccine AstraZeneca - Important Safety Information from AstraZeneca Pharmaceuticals (Ireland) DAC as approved by the HPRA

Notice type: 3rd Party Publications

Date: 22/06/2021

Important Safety Information from AstraZeneca Pharmaceuticals (Ireland) DAC regarding VAXZEVRIA/COVID-19 Vaccine AstraZeneca: contraindication in individuals with previous capillary leak syndrome

Important Safety Information - VAXZEVRIA - COVID-19 Vaccine AstraZeneca